Glenmark Pharmaceuticals Ltd has informed that the Board of Directors of the Company, at its Operations Committee Meeting held on June 27, 2008, allotted 30,600 shares to the employees of the Company on exercise of options granted to them pursuant to ESOS 2003.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment